Strategic Report Governance Financial Statements Other Information Consolidated statements of income In millions of US dollars, except share and per share data 2014 2013 2012 Notes $M $M $M Revenues: Product sales 5,830.4 4,757.5 4,252.9 Royalties 160.8 153.7 241.6 Other revenues 30.9 23.1 32.9 Total revenues 6,022.1 4,934.3 4,527.4 Costs and expenses: Cost of product sales 979.3 670.8 585.8 1 Research and development 1,067.5 933.4 953.0 1 Selling, general and administrative 2,025.8 1,651.3 1,948.0 Goodwill impairment charge 13 7.1 Gain on sale of product rights 5 88.2 15.9 18.1 Reorganization costs 6 180.9 88.2 Integration and acquisition costs 7 158.8 134.1 13.5 Total operating expenses 4,324.1 3,200.8 3,482.2 Operating income from continuing operations 1,698.0 1,733.5 1,045.2 Interest income 24.7 2.1 3.0 Interest expense 30.8 38.1 38.2 Other income expense, net 8.9 3.9 2.2 Receipt of break fee 26 1,635.4 Income from continuing operations before income taxes and equity in earnings of equity method investees 3,336.2 1,693.6 1,007.8 Income taxes 28 56.1 277.9 203.1 Equity in earnings of equity method investees, net of taxes 2.7 3.9 1.0 Income from continuing operations, net of taxes 3,282.8 1,419.6 805.7 Gain loss from discontinued operations, net of taxes 10 122.7 754.5 60.3 Net income 3,405.5 665.1 745.4 Earnings per Ordinary Share basic Earnings from continuing operations 559.6c 257.2c 145.1c Gain loss from discontinued operations 1 20.9c 136.7c 10.9c Earnings per ordinary share basic 580.5c 120.5c 134.2c Earnings per ordinary share diluted Earnings from continuing operations 555.2c 245.3c 141.0c Gain loss from discontinued operations 1 20.8c 127.8c 10.1c Earnings per ordinary share diluted 576.0c 117.5c 130.9c Weighted average number of shares millions : Basic 24 586.7 552.0 555.4 Diluted 24 591.3 590.3 593.5 1 Research and development R&D includes intangible asset impairment charges of $190.3 million for the year to December 31, 2014 2013: $19.9 million, 2012:$71.2million.
Selling, general and administrative SG&A costs include amortization of intangible assets relating to intellectual property rights acquired of$243.8 million for the year to December 31, 2014 2013: $152.0 million, 2012: $280.3 million.
The accompanying notes are an integral part of these consolidated fi financial statements.
